{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:24:47Z","timestamp":1773296687703,"version":"3.50.1"},"reference-count":0,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[1996,9,1]],"date-time":"1996-09-01T00:00:00Z","timestamp":841536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[1996,9]]},"abstract":"<jats:p>Rubella virus (RV)-specific immunoglobulin G (IgG) antibodies were studied in military recruits undergoing unselected immunization with live attenuated measles, mumps, and rubella virus (MMR) vaccine. Three different whole-RV enzyme immunoassays (EIAs) and an epitope-specific EIA with a synthetic peptide (BCH-178c) representing a heutralization domain on the RV E1 envelope protein were used. Before vaccination, 84.2, 87.7, and 84.5% of the subjects tested (n = 399) were found to be seropositive (&gt; 10 IU\/ml or assay equivalent) by the three whole-RV EIAs, respectively, while only 82.5% were seropositive by the BCH-178c EIA. Although prevaccination seropositivity rates were similar for the whole-RV EIAs (sensitivity, 94 to 100%), many sera considered seropositive by the whole-RV EIAs had E1 peptide EIA antibody levels of &lt; 10 IU\/ml (sensitivity, 77.4 to 80.7%). One month after vaccination, 97.8, 97.2, and 93.5% of the subjects who were followed (n = 356) were seropositive by the three whole-RV EIAs, respectively, while 89% had BCH-178c peptide-specific IgG titers of &gt; 10 IU\/ml. After vaccination, depending on the assay used, up to 20.6% of initially seropositive individuals exhibited a greater than fourfold increase in RV-specific IgG, while up to 47.3% showed a greater than twofold increase. Increased antibody titers after vaccination (seroboosting) were most frequently associated with low levels of BCH-178c peptide-specific IgG before vaccination. RV protein-specific IgG was also studied by immunoblot assays in a subset (n = 56) of individuals receiving the MMR vaccine. Of these, 89.4 and 91.1% exhibited RV protein (E1, E2, and C protein)-specific IgG before and after vaccination, respectively. Seroboosting (two- to fourfold increase in EIA titers of individuals seropositive by the whole-RV EIA before vaccination) was usually accompanied by a shift in the IgG immunoblot pattern from a single (E1) to multiple (E1-E1, E1-C, or E1-E2-C) specificities, suggesting exposure of new epitopes as a result of viral replication.<\/jats:p>","DOI":"10.1128\/jcm.34.9.2210-2218.1996","type":"journal-article","created":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T21:09:59Z","timestamp":1578344999000},"page":"2210-2218","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":21,"title":["Rubella reimmunization: comparative analysis of the immunoglobulin G response to rubella virus vaccine in previously seronegative and seropositive individuals"],"prefix":"10.1128","volume":"34","author":[{"given":"L A","family":"Mitchell","sequence":"first","affiliation":[{"name":"Department of Pathology, University of British Columbia, Vancouver, Canada. leslie@wpog.childhosp.bc.ca"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M K","family":"Ho","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of British Columbia, Vancouver, Canada. leslie@wpog.childhosp.bc.ca"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J E","family":"Rogers","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of British Columbia, Vancouver, Canada. leslie@wpog.childhosp.bc.ca"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A J","family":"Tingle","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of British Columbia, Vancouver, Canada. leslie@wpog.childhosp.bc.ca"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R G","family":"Marusyk","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of British Columbia, Vancouver, Canada. leslie@wpog.childhosp.bc.ca"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J M","family":"Weber","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of British Columbia, Vancouver, Canada. leslie@wpog.childhosp.bc.ca"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Duclos","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of British Columbia, Vancouver, Canada. leslie@wpog.childhosp.bc.ca"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M L","family":"Tepper","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of British Columbia, Vancouver, Canada. leslie@wpog.childhosp.bc.ca"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Lacroix","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of British Columbia, Vancouver, Canada. leslie@wpog.childhosp.bc.ca"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Zrein","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of British Columbia, Vancouver, Canada. leslie@wpog.childhosp.bc.ca"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jcm.34.9.2210-2218.1996","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jcm.34.9.2210-2218.1996","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T08:01:10Z","timestamp":1646467270000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/jcm.34.9.2210-2218.1996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,9]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1996,9]]}},"alternative-id":["10.1128\/jcm.34.9.2210-2218.1996"],"URL":"https:\/\/doi.org\/10.1128\/jcm.34.9.2210-2218.1996","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,9]]},"assertion":[{"value":"1996-09-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}